Dec 7 |
KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®
|
Dec 7 |
KMDA: Amendment and Extension of Kedrab® U.S. Distribution Agreement to Generate at Least $180 Million Over First Four Years…
|
Dec 6 |
Kamada extends commercial deal for U.S. distribution; sees $180M rev over first four years
|
Dec 6 |
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years
|
Nov 21 |
Kamada: Solid Specialty Plasma Play
|
Nov 15 |
KMDA: $37.9 Million in 3Q23 Revenues; Closes $60 Million Private Placement with FIMI Opportunity Funds…
|
Nov 13 |
Kamada Ltd. (KMDA) Q3 2023 Earnings Call Transcript
|
Nov 13 |
Kamada beats Q3 top and bottom line estimates; reaffirms FY23 outlook
|
Nov 13 |
Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance
|
Nov 10 |
Kamada Q3 2023 Earnings Preview
|